HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory ActivityDenis R. St. Laurent, Lawrence B. Snyder, Jason T. Goodrich et al.|Journal of Medicinal Chemistry|2013Cited by 35
HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologiesOmar D. Lopez, Lawrence B. Snyder, Van N. Nguyen et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 29
HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamidesDenis R. St. Laurent, Lawrence B. Snyder, Makonen Belema et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 27